droxidopa has been researched along with Autonomic Failure, Pure in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Claassen, D; Lew, M | 1 |
| Gupta, F; Karabin, B; Kremens, D; Vernino, S | 1 |
| Biaggioni, I; Feirtag, M; Freeman, R; Hewitt, LA; Kaufmann, H; Low, P; Mathias, CJ; Mauney, J; Pedder, S | 1 |
| Isaacson, S; Kalu, U; Rowse, GJ; Vernino, S; White, WB; Ziemann, A | 1 |
| Goldstein, DS; Holmes, C; Kopin, IJ; Pechnik, S; Sewell, L | 1 |
3 trial(s) available for droxidopa and Autonomic Failure, Pure
| Article | Year |
|---|---|
Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial.
Topics: Aged; Autonomic Agents; Autonomic Nervous System Diseases; Blood Pressure; Dizziness; Double-Blind Method; Droxidopa; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Multiple System Atrophy; Nervous System Diseases; Parkinson Disease; Posture; Pure Autonomic Failure; Time Factors; Treatment Outcome | 2014 |
Long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension.
Topics: Adult; Aged; Aged, 80 and over; Autonomic Nervous System; Blood Pressure; Droxidopa; Female; Heart Rate; Humans; Hypertension; Hypotension, Orthostatic; Long Term Adverse Effects; Male; Middle Aged; Multiple System Atrophy; Norepinephrine; Parkinson Disease; Prodrugs; Pure Autonomic Failure; Vasoconstrictor Agents; Young Adult | 2016 |
Effects of carbidopa and entacapone on the metabolic fate of the norepinephrine prodrug L-DOPS.
Topics: Aged; Antiparkinson Agents; Blood Pressure; Carbidopa; Catechols; Double-Blind Method; Droxidopa; Drug Interactions; Female; Humans; Male; Middle Aged; Multiple System Atrophy; Nitriles; Norepinephrine; Parkinson Disease; Prodrugs; Pure Autonomic Failure; Vasoconstriction | 2011 |
2 other study(ies) available for droxidopa and Autonomic Failure, Pure
| Article | Year |
|---|---|
Initiating droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease.
Topics: Antiparkinson Agents; Disability Evaluation; Droxidopa; Drug Interactions; Humans; Hypotension, Orthostatic; Male; Middle Aged; Parkinson Disease; Pure Autonomic Failure | 2017 |
Managing neurogenic orthostatic hypotension in a patient presenting with pure autonomic failure who later developed Parkinson disease.
Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Diagnosis, Differential; Dopamine Agents; Droxidopa; Female; Humans; Hypotension, Orthostatic; Middle Aged; Pure Autonomic Failure; Syncope | 2017 |